scholarly article | Q13442814 |
P356 | DOI | 10.1158/1078-0432.CCR-13-2053 |
P8608 | Fatcat ID | release_4ksihd67vjdmfoxwkh2tkw5tme |
P932 | PMC publication ID | 3962776 |
P698 | PubMed publication ID | 24300787 |
P5875 | ResearchGate publication ID | 259154017 |
P50 | author | Stefan M. Pfister | Q39183179 |
Anat Erdreich-Epstein | Q46308678 | ||
Ashley Margol | Q56334548 | ||
David T. W. Jones | Q58388511 | ||
Floyd Gilles | Q88404064 | ||
Alexander Judkins | Q88427997 | ||
Tom Davidson | Q89355299 | ||
Marcel Kool | Q90637389 | ||
P2093 | author name string | Shahab Asgharzadeh | |
Hong Zhou | |||
Mark D Krieger | |||
Lingyun Ji | |||
Richard Sposto | |||
Jingying Xu | |||
Gregory M Shackleford | |||
Jemily Malvar | |||
Mathew Schur | |||
Nathan Robison | |||
Xiuhai Ren | |||
P2860 | cites work | Identification and characterization of NYGGF4, a novel gene containing a phosphotyrosine-binding (PTB) domain that stimulates 3T3-L1 preadipocytes proliferation | Q24295220 |
Overexpression of NYGGF4 (PID1) induces mitochondrial impairment in 3T3-L1 adipocytes | Q24299984 | ||
Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt | Q24329181 | ||
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer | Q24608391 | ||
Molecular subgroups of medulloblastoma: the current consensus | Q24615271 | ||
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors | Q28294240 | ||
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome | Q28298987 | ||
Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease | Q28588684 | ||
Effects of NYGGF4 knockdown on insulin sensitivity and mitochondrial function in 3T3-L1 adipocytes | Q28594863 | ||
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features | Q33366431 | ||
Use of the viral 2A peptide for bicistronic expression in transgenic mice | Q33369539 | ||
Pid1 induces insulin resistance in both human and mouse skeletal muscle during obesity | Q33633052 | ||
Modeling initiation of Ewing sarcoma in human neural crest cells | Q33894979 | ||
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas | Q34167499 | ||
c-Abl is an upstream regulator of acid sphingomyelinase in apoptosis induced by inhibition of integrins αvβ3 and αvβ5. | Q34374088 | ||
Identification of the ligands of protein interaction domains through a functional approach. | Q34584256 | ||
Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells | Q34650409 | ||
Novel cell lines established from pediatric brain tumors. | Q36047046 | ||
Novel mutations target distinct subgroups of medulloblastoma. | Q36143877 | ||
Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis. | Q36411906 | ||
Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma | Q36910335 | ||
Medulloblastoma comprises four distinct molecular variants | Q36920479 | ||
Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous mice | Q37002716 | ||
Rembrandt: helping personalized medicine become a reality through integrative translational research | Q37103992 | ||
Management of and prognosis with medulloblastoma: therapy at a crossroads | Q37322966 | ||
Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo | Q40146305 | ||
Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations | Q40339027 | ||
Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice | Q40545772 | ||
Growth hormone and insulin-like growth factor-I: effects on the growth of glioma cell lines | Q40790050 | ||
siRNA Selection Server: an automated siRNA oligonucleotide prediction server | Q41010535 | ||
Overexpression of TFAM protects 3T3-L1 adipocytes from NYGGF4 (PID1) overexpression-induced insulin resistance and mitochondrial dysfunction | Q42827369 | ||
Knockdown of NYGGF4 (PID1) rescues insulin resistance and mitochondrial dysfunction induced by FCCP in 3T3-L1 adipocytes | Q42829463 | ||
Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics | Q43631246 | ||
Glioblastoma survival in the United States before and during the temozolomide era. | Q44016219 | ||
Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors | Q44214973 | ||
Expression of two types of receptor for insulin-like growth factors in human malignant glioma. | Q48107992 | ||
Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop | Q48531886 | ||
Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells | Q54648645 | ||
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. | Q55469539 | ||
Insulin-like growth factor I receptor activity in human medulloblastomas. | Q55473436 | ||
Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas. | Q55474277 | ||
Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. | Q55475439 | ||
Over-expression of NYGGF4 (PID1) inhibits glucose transport in skeletal myotubes by blocking the IRS1/PI3K/AKT insulin pathway | Q83031959 | ||
P4510 | describes a project that uses | CHLA-01-MED | Q54812135 |
CHLA-01R-MED | Q54812137 | ||
CHLA-05-ATRT | Q54812145 | ||
CHLA-06-ATRT | Q54812146 | ||
CHLA-07-BSGBM | Q54812147 | ||
CHLA-259 | Q54812495 | ||
D283 Med | Q54817202 | ||
D425 Med | Q54817229 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | brain tumor | Q233309 |
cell line | Q21014462 | ||
P304 | page(s) | 827-836 | |
P577 | publication date | 2013-12-03 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | PID1 (NYGGF4), a new growth-inhibitory gene in embryonal brain tumors and gliomas | |
P478 | volume | 20 |
Q35550199 | Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target. |
Q35999183 | Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia |
Q39480138 | Inhibition of PID1/NYGGF4/PCLI1 gene expression highlights its role in the early events of the cell cycle in NIH3T3 fibroblasts. |
Q42330162 | Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemia |
Q33678251 | PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB. |
Q38957473 | Pediatric brain tumor cell lines |
Q42369040 | The Effect of Different Case Definitions of Current Smoking on the Discovery of Smoking-Related Blood Gene Expression Signatures in Chronic Obstructive Pulmonary Disease |
Q52092512 | The TORC1/2 inhibitor TAK228 sensitizes atypical teratoid rhabdoid tumors to cisplatin-induced cytotoxicity. |
Q36416243 | The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity |
Q91838867 | Unbiased Metabolic Profiling Predicts Sensitivity of High MYC-Expressing Atypical Teratoid/Rhabdoid Tumors to Glutamine Inhibition with 6-Diazo-5-Oxo-L-Norleucine |
Q35788801 | Wnt pathway in atypical teratoid rhabdoid tumors |
Search more.